Australia Biomarker Testing Services Market Size & Outlook
Related Markets
Australia biomarker testing services market highlights
- The Australia biomarker testing services market generated a revenue of USD 8.5 million in 2024 and is expected to reach USD 14.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 9.7% from 2025 to 2030.
- In terms of segment, oncology was the largest revenue generating services in 2024.
- Oncology is the most lucrative services segment registering the fastest growth during the forecast period.
Biomarker testing services market data book summary
| Market revenue in 2024 | USD 8.5 million |
| Market revenue in 2030 | USD 14.7 million |
| Growth rate | 9.7% (CAGR from 2025 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Oncology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug discovery & development, Oncology |
| Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
Other key industry trends
- In terms of revenue, Australia accounted for 1.3% of the global biomarker testing services market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biomarker testing services market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 19.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarker Testing Services Market Scope
Biomarker Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioAgilytix Labs | View profile | 501-1000 | Durham, North Carolina, United States, North America | http://www.bioagilytix.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Australia biomarker testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 55.29% in 2024. Horizon Databook has segmented the Australia biomarker testing services market based on drug discovery & development, oncology covering the revenue growth of each sub-segment from 2018 to 2030.
Australia is one of the significant biomarkers in the testing services market. The country is driven by increasing partnerships with market players to expand their market presence & strengthen their capabilities. In addition, the market is expected to witness advanced healthcare infrastructure, improved research capabilities, and the availability of highly skilled researchers.
The growing demand for pharmaceutical/biopharmaceutical products also increases the need for market services. Therefore, with the increasing focus on advancing drug discovery and development, there will be an increased demand for biomarker testing services to ensure these new medications' safety, efficacy, and regulatory compliance.
Reasons to subscribe to Australia biomarker testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia biomarker testing services market databook
-
Our clientele includes a mix of biomarker testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biomarker testing services market , including forecasts for subscribers. This country databook contains high-level insights into Australia biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia biomarker testing services market size, by services, 2018-2030 (US$M)
Australia Biomarker Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
